Pharma & Biotech

Novo Nordisk finds itself navigating one of its most challenging periods, as the Danish pharmaceutical giant contends with a rapidly...

The proposed acquisition of CureVac by its larger competitor BioNTech has moved significantly closer to completion following a crucial regulatory...

Shares of Assembly Biosciences experienced a powerful upward movement following the release of compelling clinical trial data for its genital...

Bruker's stock is currently presenting investors with a complex picture. While recent trading sessions have revealed promising short-term recovery signals,...

Amid turbulent equity markets, Thermo Fisher Scientific stands out with notable resilience. This life sciences behemoth isn't just rewarding shareholders...

Replimune Group Inc. finds itself navigating turbulent waters as multiple challenges converge. The biotechnology firm faces substantial headwinds from regulatory...

Investors in Corbus Pharmaceuticals are bracing for a pivotal market catalyst this weekend. The biotechnology firm is scheduled to present...

Pharmaceutical giant Eli Lilly is capturing renewed attention from market experts, with two prominent research firms simultaneously upgrading their assessments...

In a decisive move for Germany's biotechnology sector, the Federal Cartel Office has granted unconditional approval for BioNTech's proposed acquisition...

Viking Therapeutics is experiencing the downside of its ambitious growth strategy. Recent clinical developments have tempered investor enthusiasm for the...